TY  - JOUR
T1  - ONcology drugs enter the us market faster than in europe but cost more
AU  - Mitka M
Y1  - 2012/08/08
N1  - 10.1001/jama.2012.9535
JO  - JAMA
SP  - 555
EP  - 555
VL  - 308
IS  - 6
N2  - 
The analysis found that oncology drug prices are on average 9% lower in the 4 European countries examined than in the United States. And the amount of the cost borne by patients is significantly lower in these countries than in the United States. The Tufts report estimated that US patients' coinsurance rates per covered drug was 33%. In contrast, patients pay a maximum of $13 per prescription in Germany and $10 per prescription in the United Kingdom. In France and the Netherlands, patients have no out-of-pocket payments for cancer drugs.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.9535
UR  - http://dx.doi.org/10.1001/jama.2012.9535
ER  -